NCT00004215View on ClinicalTrials.gov

Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1999

Primary Completion Date

August 31, 2000

Study Completion Date

August 31, 2000

Conditions
AnemiaLeukemiaNeutropeniaThrombocytopenia
Interventions
BIOLOGICAL

filgrastim

BIOLOGICAL

leridistim

DRUG

cytarabine

DRUG

daunorubicin hydrochloride

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER